Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
AIRR 1st quartile vs. SP 500 LT 1.5%, 10 yr. 3.7%, 5yr. 8.9%, 3 yr. 13.8%, 1yr. 34.2. Also Down Cycle vs SP 500 2021-2022 (9 mos.) 8.7%. Great Owl and my largest holding.
@BaluBalu MFOP is vastly superior to M*. It's easy to learn and navigate. You'll have to register at MFO with a user name and password. Weekly display periods: Month-To-Date (MTD) and Weeks-To-Date (WTD), YTD plus MTD . It costs $120.
@WABAC FWIW: The correlation between MRFOX and SPGP is .87 (So it's not really an alternative); MRFOX LT APR is 16.4%; SPGP is 14.4%; STDEV MRFOX 13.2; SPGP 16.4; MRFOX = Great Owl; SPGP No. Also, SPGP has underperformed the SP500 YTD, 1yr.; 3yr.; a…
CPAI is systematic, a diversifier, and defensive. Its aim is capital appreciation. It uses multiple machine models and AI to select the stocks while adjusting to different factors to seek outperformance to the market. It is new to the portfolio. (BT…
@ stayCalm: MRFOX LT Returns as of 9/30: APR 17.0%; MAXDD -15.7% (202003; Recovery Mos. 7; ST Dev 13.2%; DSEV 7.3%; Ulcer Index 3.2%; Sharp Ratio 1.14%; Sortino Ratio 2.07%; Martin Ratio 4.76; MFO Rating 5 (Best); Peer Count 108; APR vs. Peer 3.6%; …
I've held the fund since 2019, and so I've benefitted from its returns since then. My spouse holds even more of it but hasn't owned it as long in both an IRA and regular account. She isn't interested in selling any of it.
@BaluBalu MRFOX ER is 1.01%. Its 2023 distro was 0.13; 2022 distro 0.03. (This info is from Barron's.) I will be selling 60% of my IRA holding in the fund later this month but keeping 22% of my regular account. The reason is that I want to diversify…
You might consider CPAI (Counterpoint Quant Equity ETF, a multi-cap growth fund. Age 0.8 years; 11.96 financials (not heavy); YTD return 33.4% through September beats SP 500 by 5.7%; ER .75.
@Baseball_Fan In response to your July 21 question about VELIX being a 130/30, the co-manager, Lisa Wesolek, with whom I have been pretty tight since my profile ran, writes as follows. "Yes, we did initially intend it to be a 130/30. We knew they ha…
VELIX Portfolio Parameters: Benchmark Russell 100; Typical Number of Positions Long: 40-60, Short 20-30; Typical Net Exposure 100%; Typical Total Long Exposure 80-100% of net assets; Total Short Exposure 0-30% of net assets; Maximum Industry Exposur…
Yes, as a Long/Short Equity Product, VELIX is worth considering. It's a 3.8 year-old fund with only $67M in AUM. Its LT APR is 15.6%. It does well on the downside (202201-202209) beating the SP 500 by 10.4%; however, Immediately afterward (202210-20…
@Baseball Fan The PM writes, "Some of our stocks are pretty highly valued, but not high enough for us to sell or pare back. Some are relatively inexpensive but not cheap enough to buy more. So there’s an array but little movement. I would say that i…
@BaluBalu Around July 15th is when MRFOX updates the website with new info. Updating after quarter-end is the most efficient for them. The PM also writes, "However, I'll kick this to our marketing and ops folks to see if they have thoughts. And then…
@BaluBalu The only thing I can add is that she isn't sure about when to close the fund, specifically would it be unannounced or be announced later. She said, "I don’t know but we don't particularly want to accelerate the pace…."
@finder Here's what I know about closure. Since I profiled the fund in February 2019, the assets in MRFOX have increased about 82%. But Elise Hoffman writes today, "We seem to have room to grow still, based on how the market has grown and the fact t…
@WABAC MRFOX has limited brokerage availability in order to control inflows. When it only existed as a separate account, $$$ flowed in heavily when the market turned down.
@Baseball_Fan @JD_co Inimitable fund. Profiled it here in Feb. 2019. Have a personal friendship with Ms. Hoffman and communicate with her often (latest yesterday.) Here's her Letter to Clients December 2013 https://www.marshfieldinc.com/wp-content/u…
MRFOX, which I profiled in Feb. 2019 I believe. +3% LT vs. SP500, 3.3% 5yr; .9% 3yr; 4.0% 1yr. No down years in its 7.5 year history. YTD +9.20%. Mid-cap growth.
It's the 485A filing that they just did for their annual update to their funds. This might have gotten picked up because they incorporated Income Opps into the trust's prospectus and SAI. Before, Income Opps was on its own.
FWIW Have been investing with VG for 37 years and only have had a few minor issues/misunderstandings about what I needed. In fact, a few months ago they listed a fund family I argued for, and I have now owned one of their products, which I'll profil…
